TrialCell transplantation2019

Anti-Platelet Therapy in Mild Cerebral Infarction Patients on the Basis of CYP2C19 Metabolizer Status.

Hu Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.